{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:29:23Z","timestamp":1786804163823,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Functional variants of the cytotoxic T-lymphocyte antigen-4 (CTLA4) could contribute to the pathogenesis of disorders characterized by abnormal T-cell responses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Presentation:<\/jats:title>\n            <jats:p>We report a case of a 13-year-old girl who first presented with polyarticular juvenile idiopathic arthritis poorly responsive to treatment. During the following years the patient developed cytopenias, chronic lymphoproliferation, high values of T-cell receptor \u03b1\u03b2<jats:sup>+<\/jats:sup> CD4<jats:sup>-<\/jats:sup> CD8<jats:sup>-<\/jats:sup> double-negative T cells and defective Fas-mediated T cells apoptosis. Autoimmune lymphoproliferative syndrome was diagnosed and therapy with mycophenolate mofetil was started, with good hematological control. Due to the persistence of active polyarthritis, mycophenolate mofetil was replaced with sirolimus. In the following months the patient developed hypogammaglobulinemia and started having severe diarrhea. Histologically, duodenitis and chronic gastritis were present. Using the next generation sequencing-based gene panel screening, a CTLA4 mutation was detected (p.Cys58Serfs*13). At the age of 21 the patient developed acute autoimmune hemolytic anemia; steroid treatment in combination with abatacept were started with clinical remission of all symptoms, even arthritis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Targeted immunologic screening and appropriate genetic tests could help in the diagnosis of a specific genetically mediated immune dysregulation syndrome, allowing to select those patients who can take advantage of target therapy, as in the case of abatacept in CTLA4 deficiency.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002120","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:34:08Z","timestamp":1614386048000},"page":"e1168-e1172","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Underlying CTLA4 Deficiency in a Patient With Juvenile Idiopathic Arthritis and Autoimmune Lymphoproliferative Syndrome Features Successfully Treated With Abatacept\u2014A Case Report"],"prefix":"10.1097","volume":"43","author":[{"given":"Marta","family":"Mazzoni","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic, and Maternal and Infant Health (DINOGMI), University of Genoa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Dell\u2019Orso","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Grossi","sequence":"additional","affiliation":[{"name":"Molecular Genetic Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ceccherini","sequence":"additional","affiliation":[{"name":"Molecular Genetic Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Viola","sequence":"additional","affiliation":[{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto G. Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Terranova","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Micalizzi","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Guardo","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Massaccesi","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Palmisani","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Calvillo","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fioredda","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Malattia","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic, and Maternal and Infant Health (DINOGMI), University of Genoa"},{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto G. Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Dufour","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Rehabilitation, Ophthalmology, Genetic, and Maternal and Infant Health (DINOGMI), University of Genoa"},{"name":"Clinica Pediatrica e Reumatologia, IRCCS Istituto G. Gaslini, Genoa, Italy"},{"name":"Sechenov First Moscow State Medical University, Moscow, Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Miano","sequence":"additional","affiliation":[{"name":"Haematology Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.1255904","article-title":"Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4","volume":"345","author":"Kuehn","year":"2014","journal-title":"Science"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.3746","article-title":"Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations","volume":"20","author":"Schubert","year":"2014","journal-title":"Nat Med"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2016-04-712612","article-title":"CHAI and LATAIE: new genetic diseases of CTLA-4 checkpoint insufficiency","volume":"128","author":"Lo","year":"2016","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2156-5-2","article-title":"Complex genetic predisposition in adult and juvenile rheumatoid arthritis","volume":"5","author":"Miterski","year":"2004","journal-title":"BMC Genet"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/art.23602","article-title":"Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis","volume":"58","author":"Prahalad","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/09674845.2020.1730626","article-title":"PADI4 (rs2240340), PDCD1 (rs10204525), and CTLA4 (231775) gene polymorphisms and polyarticular juvenile idiopathic arthritis","volume":"77","author":"Ali","year":"2020","journal-title":"Br J Biomed Sci"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3892\/etm.2015.2295","article-title":"Study of the association between CD28\/CTLA-4 expression and disease activity in juvenile idiopathic arthritis","volume":"9","author":"Zhang","year":"2015","journal-title":"Exp Ther Med"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12997","article-title":"Immune deficiency and autoimmunity in patients with CTLA\u20104 (CD152) mutations","volume":"190","author":"Verma","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/tra.12069","article-title":"The BEACH is hot: a LYST of emerging roles for BEACH-domain containing proteins in human disease","volume":"14","author":"Cullinane","year":"2013","journal-title":"Traffic"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.4049\/jimmunol.174.8.4803","article-title":"Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells","volume":"174","author":"Mead","year":"2005","journal-title":"J Immunol"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/blood-2015-11-685024","article-title":"Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome","volume":"128","author":"V\u00f6lkl","year":"2016","journal-title":"Blood"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2015.09.025","article-title":"The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency","volume":"137","author":"G\u00e1mez-D\u00edaz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12969-019-0388-4","article-title":"in children with LRBA deficiency\u2014case report and literature review","volume":"17","author":"Semo","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bjh.13533","article-title":"Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience","volume":"171","author":"Miano","year":"2015","journal-title":"Br J Haematol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjh.13010","article-title":"Sirolimus for the treatment of multi-resistant autoimmune haemolytic anaemia in children","volume":"167","author":"Miano","year":"2014","journal-title":"Br J Haematol"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1097\/MPH.0000000000001708","article-title":"Unusual late-onset enteropathy in a patient with lipopolysaccharide-responsive beige-like anchor protein (LRBA) deficiency","volume":"42","author":"Maggiore","year":"2020","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:00:15Z","timestamp":1754341215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002120","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"2020-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}